<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21984" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fructose-1-Phosphate Aldolase Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Umair</given-names>
          </name>
          <aff>University of Health Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Jyotsna</given-names>
          </name>
          <aff>Riverside Community Hospital/University of California Riverside School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Umair Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jyotsna Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21984.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Fructose 1-phosphate aldolase deficiency or hereditary fructose intolerance (HFI) is an autosomal recessive disorder caused by the deficiency in aldolase B (fructose-1, 6-bisphosphate aldolase), an enzyme responsible for the cleavage of fructose-1-phosphate. To avoid the morbidity and mortality associated with this condition, it must be promptly diagnosed and managed. This activity reviews the evaluation and management of HFI and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the role of aldolase B in fructose metabolism.</p></list-item><list-item><p>Describe the pathophysiology of fructose 1-phosphate aldolase deficiency.</p></list-item><list-item><p>Review the long term management of patients with fructose 1-phosphate aldolase deficiency.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication and improve outcomes in cases of fructose 1-phosphate aldolase deficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21984&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21984">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21984.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fructose 1-phosphate aldolase deficiency or hereditary fruc&#x000ad;tose intol&#x000ad;er&#x000ad;ance (HFI) is an auto&#x000ad;so&#x000ad;mal reces&#x000ad;sive dis&#x000ad;order, caused by the deficiency in aldolase B (fructose-1, 6-bisphosphate aldolase), an enzyme responsible for the cleavage of fructose-1-phosphate. HFI is a metabolic disorder that usually manifests around 4-6 months of age when weaning is started. The inheritance pattern is autosomal recessive, and there is a 25% chance of having a child with HFI if both parents are heterozygotes.</p>
        <p>The mainstay of treatment is the dietary restriction of fructose, sorbitol,&#x000a0;and sucrose. Life expectancy is normal in these individuals if appropriate precautionary measures are taken. The disorder leads to a toxic accumulation of fructose-1-phosphate in the liver and renal tubules.</p>
      </sec>
      <sec id="article-21984.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>HFI is caused by the deficiency of aldolase B, an isoenzyme that is expressed in the liver, kidney, and intestinal tissue, which is important in fructose metabolism. The enzyme catalyzes different reactions including cleavage of fructose-1-phosphate and reversible cleavage of fructose-1, 6-bisphosphate (FBP) into glyceraldehyde phosphate and dihydroxyacetone phosphate (DHAP).</p>
        <p>The&#x000a0;aldolase B gene is located on chromosome 9q22,&#x000a0;and various mutations have been identified.<xref ref-type="bibr" rid="article-21984.r1">[1]</xref>&#x000a0;The most frequent of these mutations are A150P,&#x000a0;A149P, and A174D.<xref ref-type="bibr" rid="article-21984.r2">[2]</xref><xref ref-type="bibr" rid="article-21984.r3">[3]</xref>&#x000a0;The severity of the disease depends on the aldolase B activity and it can remain undiagnosed in some individuals due to self-imposed dietary restriction.<xref ref-type="bibr" rid="article-21984.r4">[4]</xref></p>
      </sec>
      <sec id="article-21984.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>HFI has an autosomal recessive inheritance pattern affecting both genders equally. The prevalence of the disease is estimated to be around 1 in 20,000 births in the US,&#x000a0;and 1 in 26,100 live births in Europe.<xref ref-type="bibr" rid="article-21984.r5">[5]</xref><xref ref-type="bibr" rid="article-21984.r6">[6]</xref></p>
      </sec>
      <sec id="article-21984.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Aldolase B is the key enzyme in fructose metabolism, and its deficiency can lead to a toxic accumulation of fructose-1-phosphate. Fructose is rapidly converted into fructose-1-phosphate by fructokinase, leading to depletion of inorganic phosphate and ATP. This lethal cascade leads to increased production of uric acid and a release of magnesium along with impaired protein synthesis and metabolic disturbances, which are believed to be responsible for hepatic and renal dysfunction.<xref ref-type="bibr" rid="article-21984.r7">[7]</xref></p>
        <p>Aldolase B is responsible for the reversible conversion of fructose-1-phosphate to 3 carbon sugars. In individuals deficient in aldolase B activity, this causes an accumulation of fructose-1-phosphate, leading to subsequent inhibition of both glycolytic and gluconeogenesis&#x000a0;pathways, thus&#x000a0;causing hypoglycemia in individuals.&#x000a0;</p>
        <p>The pathogenesis for renal tubular dysfunction is believed to be due to decreased activity of vacuolar-ATPase, responsible for endosomal acidification, and proton secretion, because of the deficiency of the aldolase enzyme leading to renal tubular dysfunction.<xref ref-type="bibr" rid="article-21984.r8">[8]</xref>&#x000a0;</p>
        <p><bold>Characteristic Metabolic Disturbances</bold><xref ref-type="bibr" rid="article-21984.r9">[9]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Lactic acidosis</p>
          </list-item>
          <list-item>
            <p>Hypophosphatemia</p>
          </list-item>
          <list-item>
            <p>Hyperuricemia</p>
          </list-item>
          <list-item>
            <p>Hypermagnesemia</p>
          </list-item>
          <list-item>
            <p>Hyperalaninemia</p>
          </list-item>
        </list>
        <p>
<bold>Characteristic Clinical Findings</bold>
<xref ref-type="bibr" rid="article-21984.r9">[9]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nausea, vomiting</p>
          </list-item>
          <list-item>
            <p>Abdominal distress</p>
          </list-item>
          <list-item>
            <p>Chronic growth restriction</p>
          </list-item>
          <list-item>
            <p>Failure to thrive</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21984.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Histological Findings on Liver Biopsy</bold>
<xref ref-type="bibr" rid="article-21984.r10">[10]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Giant cell transformation along with steatosis, fibrosis, and cirrhosis</p>
          </list-item>
        </list>
        <p>
<bold>Electron Microscopy/Ultrastructural Findings on Liver Biopsy</bold>
<xref ref-type="bibr" rid="article-21984.r11">[11]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Concentric and irregularly disposed membranous arrays present in the glycogen areas of most hepatocytes</p>
          </list-item>
          <list-item>
            <p>Marked rarefaction of the cytoplasm&#x000a0;(&#x02018;fructose holes&#x02019;)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21984.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>It is important to evaluate the dietary history of the patient. Symptoms generally appear when weaning is started in an infant around 4-6 months of age. Clinically, it can range from recurrent vomiting, abdominal bloating and diarrhea, yellow discoloration of eyes (icterus), hepatomegaly, and failure to thrive in infants. Depending on the activity level of the aldolase B enzyme, the symptoms may vary, and commonly these individuals form an aversion to food rich in fructose and sucrose. Some cases remain undiagnosed for many years.</p>
        <p>In heterozygous individuals (carriers), they are generally asymptomatic but hyperuricemia is observed in some of the cases with a predisposition to gouty arthritis.<xref ref-type="bibr" rid="article-21984.r12">[12]</xref><xref ref-type="bibr" rid="article-21984.r13">[13]</xref></p>
      </sec>
      <sec id="article-21984.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of HFI is primarily&#x000a0;based on clinical findings and metabolic disturbances observed in individuals after the ingestion of fructose, sucrose, or sorbitol containing food. The fructose tolerance test (FTT), is the standard diagnostic test. It is not routinely recommended due to resulting hypoglycemia and hypophosphatemia in adults, as well as the difficulty in performing the test in infants and children. A non-invasive test for HFI is molecular genetic testing for the&#x000a0;ALDOB gene. An invasive test for HFI is a liver biopsy and a check for aldolase B activity.</p>
      </sec>
      <sec id="article-21984.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In an emergency, the patient can present with lethargy, seizures, comatose, or with hepatic and renal failure. &#x000a0;The management in the acute setting includes intravenous glucose (dextrose) administration, correction of possible metabolic acidosis, and supportive treatment. Such individuals need active management and a multi-specialty team approach.</p>
        <p>The mainstay of treatment for HFI is dietary adherence, as well as the prevention of acute manifestations. Care should be taken to avoid fructose-containing fluids. As these individuals adhere to a specific diet, this can lead to micronutrient deficiencies, which can be prevented by daily supplementation with multivitamins (folate and vitamin C).</p>
      </sec>
      <sec id="article-21984.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Infectious hepatitis, sepsis, or disseminated intravascular coagulation</p>
          </list-item>
          <list-item>
            <p>Autoimmune liver disease</p>
          </list-item>
          <list-item>
            <p>Neonatal hemochromatosis</p>
          </list-item>
          <list-item>
            <p>Toxic ingestion</p>
          </list-item>
          <list-item>
            <p>Alpha-1-antitrypsin deficiency</p>
          </list-item>
          <list-item>
            <p>Tyrosinemia</p>
          </list-item>
          <list-item>
            <p>Galactosemia</p>
          </list-item>
          <list-item>
            <p>Urea cycle disorders</p>
          </list-item>
          <list-item>
            <p>Citrin deficiency</p>
          </list-item>
          <list-item>
            <p>Fatty acid oxidation disorders (including MCAD deficiency, LCHAD deficiency, and VLCAD deficiency)</p>
          </list-item>
          <list-item>
            <p>Maple syrup urine disease</p>
          </list-item>
          <list-item>
            <p>Wilson disease</p>
          </list-item>
          <list-item>
            <p>Glycogen storage disease (GSD)</p>
          </list-item>
          <list-item>
            <p>Disorders of mitochondrial DNA depletion</p>
          </list-item>
          <list-item>
            <p>Transaldolase deficiency</p>
          </list-item>
          <list-item>
            <p>Congenital disorders of glycosylation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21984.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Fructose intolerance has an excellent prognosis, provided the individual follows strict dietary compliance. If the disorder is diagnosed early in its course, and management is initiated in a timely manner, then the individual can have normal cognitive development and life span.</p>
      </sec>
      <sec id="article-21984.s12" sec-type="Complications">
        <title>Complications</title>
        <p>If dietary restrictions are not followed it can lead to serious complications such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe hypoglycemia possibly leading to coma</p>
          </list-item>
          <list-item>
            <p>Lactic acidosis</p>
          </list-item>
          <list-item>
            <p>Hepatic dysfunction</p>
          </list-item>
          <list-item>
            <p>Renal dysfunction and metabolic abnormalities</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21984.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient and family education on proper management, especially compliance with dietary restriction&#x000a0;is essential for patients affected with this disease. Early diagnosis and management&#x000a0;have profound effects on the neurodevelopment of these patients. Genetic counseling is recommended in families proven to have a genetic mutation of the ALDOB gene.</p>
      </sec>
      <sec id="article-21984.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Early&#x000a0;diagnosis and treatment of the condition have an excellent prognosis. Multi-specialty care is needed.</p>
          </list-item>
          <list-item>
            <p>HFI is an autosomal recessive disorder. Genetic counseling is important as both the parents of the affected individual are obligate heterozygotes (carriers) and there is a 25% chance of having a child with HFI, 50% chance of being a carrier, and 25% chance of not being affected.</p>
          </list-item>
          <list-item>
            <p>Educating the child and adults regarding the importance of dietary restriction and adherence is needed. The primary objective of dietary restriction is to reduce morbidity and mortality associated with this disorder.</p>
          </list-item>
          <list-item>
            <p>HFI in a pregnant mother does not pose any risk to the mother or child if strict dietary adherence is practiced during the pregnancy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21984.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Fructose 1-phosphate aldolase deficiency or HFI is a relatively rare autosomal recessive disorder, but a timely diagnosis is imperative to avoid morbidity and mortality associated with this condition. The condition is best managed by an interprofessional team that includes a geneticist, dietician, pediatrician, hepatologist, nephrologist, and nurse.</p>
      </sec>
      <sec id="article-21984.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21984&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21984">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/fructose-1-phosphate-aldolase-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21984">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21984/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21984">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21984.s17">
        <title>References</title>
        <ref id="article-21984.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tolan</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Penhoet</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Characterization of the human aldolase B gene.</article-title>
            <source>Mol Biol Med</source>
            <year>1986</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-64</page-range>
            <pub-id pub-id-type="pmid">3016456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esposito</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Santamaria</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vitagliano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ieno</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fiori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Parenti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zancan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zagari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salvatore</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene.</article-title>
            <source>Hum Mutat</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>534</fpage>
            <pub-id pub-id-type="pmid">15532022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tolan</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Screening for hereditary fructose intolerance mutations by reverse dot-blot.</article-title>
            <source>Mol Cell Probes</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-40</page-range>
            <pub-id pub-id-type="pmid">10024431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rellos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Hereditary fructose intolerance.</article-title>
            <source>J Med Genet</source>
            <year>1998</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>353</fpage>
            <page-range>353-65</page-range>
            <pub-id pub-id-type="pmid">9610797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esposito</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vitagliano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Santamaria</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zagari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salvatore</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance.</article-title>
            <source>FEBS Lett</source>
            <year>2002</year>
            <month>Nov</month>
            <day>06</day>
            <volume>531</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-6</page-range>
            <pub-id pub-id-type="pmid">12417303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rischewski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>von Weihe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niederhaus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schneppenheim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baerlocher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kohlsch&#x000fc;tter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muntau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Posselt</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Steinmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schneppenheim</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.</article-title>
            <source>Hum Mutat</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>594</fpage>
            <pub-id pub-id-type="pmid">15880727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richardson</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Patten</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of acidosis in hereditary fructose intolerance.</article-title>
            <source>Metabolism</source>
            <year>1979</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>1133</fpage>
            <page-range>1133-8</page-range>
            <pub-id pub-id-type="pmid">491970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holliday</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Gluck</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.</article-title>
            <source>J Biol Chem</source>
            <year>2001</year>
            <month>Aug</month>
            <day>10</day>
            <volume>276</volume>
            <issue>32</issue>
            <fpage>30407</fpage>
            <page-range>30407-13</page-range>
            <pub-id pub-id-type="pmid">11399750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gaughan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ayres</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <chapter-title>Hereditary Fructose Intolerance</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2015</year>
            <month>12</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">26677512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ptak</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>Subcellular pathology of hereditary fructose intolerance.</article-title>
            <source>Am J Med</source>
            <year>1968</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>910</fpage>
            <page-range>910-21</page-range>
            <pub-id pub-id-type="pmid">5656202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Hetenyi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Ultrastructural hepatocellular alterations induced by in vivo fructose infusion.</article-title>
            <source>Lab Invest</source>
            <year>1970</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>370</fpage>
            <page-range>370-9</page-range>
            <pub-id pub-id-type="pmid">5429537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seegmiller</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Kemp</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>McAlindon</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Dieppe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rajagopalan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Radda</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>87</volume>
            <issue>21</issue>
            <fpage>8326</fpage>
            <page-range>8326-30</page-range>
            <pub-id pub-id-type="pmid">2236043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21984.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oberhaensli</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Rajagopalan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Radda</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Herschkowitz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy.</article-title>
            <source>Lancet</source>
            <year>1987</year>
            <month>Oct</month>
            <day>24</day>
            <volume>2</volume>
            <issue>8565</issue>
            <fpage>931</fpage>
            <page-range>931-4</page-range>
            <pub-id pub-id-type="pmid">2889861</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
